News
Search here results
search-total-matching162search-total-matching- Global Media Interest in MRC Centre Channelopathy Study Published in the Lancet | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- 2018 Update in Neuromuscular Disorders Course | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- International Centres visit ¹û¶³Ó°Ôº for MRC Global Centre planning workshop | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- Orphazyme assumes sponsorship of Phase II/III arimoclomol sIBM trial | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- Collaborative work with Dumonceaux and Voit in Nature Communications has important implications for myostatin therapies | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- NMCCC finalists at prestigious HSJ awards | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- Accelerated approval granted for new drug for muscular dystrophy | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- New paper in Neuron highlights importance of slow axonal transport in motor neuron function; implications for neuromuscular diseases | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- Support our team on the 10k run for neuromuscular diseases | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
- Successful MRC centre study in inclusion body Myositis provides clues to new treatment approaches in Alzheimer's diseases and ALS | Queen Square Centre for Neuromuscular Diseases - ¹û¶³Ó°Ôº – ¹û¶³Ó°Ôº
Please enable JavaScript to use this page or